Sen. Josh Hawley: "Are you concerned with the continuation and expansion of Chinese gain-of-function research?"
— Townhall.com (@townhallcom) August 3, 2022
Dr. Quay: "They were doing synthetic biology on a cloning vector of the Nipah virus, which is 60% lethal. We just experienced a 1% lethal virus..." pic.twitter.com/ydeY1Gj8OE
2022年8月6日土曜日
英国政府統計局から「新型コロナワクチン=死因すり替え目的のバイオ殺人兵器」のConfirmation
2021年8月27日金曜日
Dr. Ebright Before Senate: Gain-of-Function Research is Popular Because It’s ‘Fast, Easy, Fundable, and Publishable’
By Micky Wootten | August 5, 2022 | 3:29pm EDTSince the start of the COVID-19 pandemic, there has been an effort to reveal whether the National Institutes of Health (NIH) funded GOF research at the Wuhan Institute of Virology in China. In testimony before Congress in May 2021, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, said, “The NIH and NIAID categorically has not funded gain-of-function research to be conducted in the Wuhan Institute of Virology.”(CNS News) – During the first congressional hearing on gain-of-function research in relation to COVID, expert witness Dr. Richard Ebright, the board of governors professor of Chemical Biology at Rutgers University, revealed what he believes are the four driving incentives behind this work in the scientific community: It’s fast, easy, fundable, and publishable.
The Aug. 3 hearing was held by the Senate Subcommittee on Emerging Threats and Spending Oversight. Senator Rand Paul (R-Ky.), a medical doctor and critic of gain-of-function research, is the ranking member on the committee.
https://cnsnews.com/article/washington/micky-wootten/dr-ebright-senate-gain-function-research-popular-because-its-fast
2 件のコメント:
生かすためと言いながら殺しまくった
けど、それウィルスのせいだからで切り抜けられるはずだった
今までできたことなんだから
できる予定でバレることもなかった のにバレるという
まぁ、現代をナメた老害の壮大な浅知恵だった と。
このおじーさんは、自殺しないのかねぇ
最期まで的になる覚悟してんのかねぇ
骨の髄までやるべきことが沁みついているから
自殺は考えられない
今までの戦争責任のあるトップは自殺してないよね
ナチスにしても731豚にしても革命起こした連中も
悔恨しそうなそぶりを見せたら即自殺に見せかけた★
サタンが自殺したなんて歴史上聞いたことない
コメントを投稿